COMMUNIQUÉS West-GlobeNewswire

-
Mission Pharmacal enters into agreement with MainPointe Pharmaceuticals to purchase and license Mission’s consumer products
21/02/2018 -
Genmab 2017 Annual Report
21/02/2018 -
Orange County Plastic Surgeon Recognized as OCMA Physician of Excellence and Orange Coast Magazine Top Doctor
21/02/2018 -
Provant Health Chief Information Officer Discusses CIO Roles
21/02/2018 -
Aino Health AB (publ): signs contract with Region Västmanland
21/02/2018 -
Dynavax’s HEPLISAV-B™ [Hepatitis B Vaccine (Recombinant), Adjuvanted] Recommended by CDC Advisory Committee on Immunization Practices for the Prevention of Hepatitis B in Adults
21/02/2018 -
Pascal Biosciences Identifies Molecules in Cannabis That Stimulate the Immune System to Destroy Tumor Cells
21/02/2018 -
Cognoa Hits Major Milestone Towards First AI-Based Autism Diagnostic
21/02/2018 -
Medtronic Introduces MiniMed(TM) Mio(TM) Advance Infusion Set for People with Diabetes
21/02/2018 -
Imprivata to Showcase Customer Success with E-prescribing for Opioids at HIMSS18
21/02/2018 -
La Jolla Pharmaceutical Company Announces the Treatment of First Patient in GIAPREZA™ (angiotensin II) Pediatric Study
21/02/2018 -
CBS News Covers AXIM Biotech’s Patent Filing for Controlled-Release Chewing Gum to Provide Treatment for Opioid Addiction
21/02/2018 -
Tyme Technologies Appoints Tommy G. Thompson to Board of Directors
21/02/2018 -
Abeona Therapeutics Announces Upcoming Conference Participation
21/02/2018 -
FIT Biotech Oy: FIT Biotech Oy's Board of Directors has decided on the directed share issue without payment to the Company itself
21/02/2018 -
CRISPR Therapeutics to Participate in Four Upcoming Investor Conferences
21/02/2018 -
Eyenovia Advances MicroPine for Myopia into Phase III Clinical Development and Appoints Stanford Professor Dr. Douglas Fredrick to its Scientific Advisory Board and Myopia Program Steering Committee
21/02/2018 -
Evoke Pharma Schedules Conference Call and Webcast for Fourth Quarter and Full-Year 2017 Financial Results
21/02/2018 -
Tower One Announces Final Approval and Implementation of Warrant Incentive Program and Warrant Listing on Canadian Securities Exchange
21/02/2018
Pages